Tag: Aortic Research Consortium
From Brazil to Baylor: Oderich assumes coveted role at cardiovascular ‘powerhouse’
Following in the footsteps of some of the pioneers of cardiovascular surgery, Gustavo Oderich, MD, recently stepped into position as the Michael E. DeBakey...
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains...
Despite a “dramatic” decrease in the use of prophylactic cerebrospinal fluid drains (CSFDs) for the prevention of spinal cord ischemia (SCI) in patients undergoing...
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research...
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs.
Despite...
Vascular Specialist–January 2024
In this issue:
Coding: Increasing complexity and lost RVUs—a drop in the ocean?
The utility of renal stenting in hemodialysis patients: one in five...
U.S. Aortic Research Consortium maps out F/BEVAR preoperative risk factors for...
A series of preoperative risk factors—including currently smoking, chronic kidney disease (CKD), congestive heart failure (CHF), aneurysm size greater than 7cm, more advanced...
Complex TAAA: US ARC IDE registry reports better survival vs. real-world...
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic...
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair...